Drugs / BioChaperone® Combo 75/25
last change Dec 2017 re-read 2 minutes ago

BioChaperone® Combo 75/25

Developed for
type 2 diabetes mellitus
Investigated by
Adocia

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03180710 Jun → Aug 2017 type 2 diabetes mellitus Adocia Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BioChaperone Combo 75/25 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03180710
Route Subcutaneous “Single subcutaneous injection of 0.6 U/kg” NCT03180710